Cenobamate Shows Promise for Kids with Focal Epilepsies
Researchers studied the use of a medication called cenobamate in children with focal epilepsies and developmental epileptic encephalopathies.
Access research focused on epilepsy in infants, children, and teens, including causes, treatments, developmental impacts, and family support strategies.
Researchers studied the use of a medication called cenobamate in children with focal epilepsies and developmental epileptic encephalopathies.
Researchers studied the effects of rapid genomic testing on children who were seriously ill and had severe epilepsy.
Researchers studied how neurocognitive issues, behavior problems, and the treatment process affect stress levels in parents of children with epilepsy.
Researchers studied the relationship between specific genetic variations in the SCN1A gene and resistance to sodium valproate, a common epilepsy medication, in children.
Researchers studied how cognitive function is affected in children with epilepsy, particularly those who might need surgery.
Researchers conducted a study to explore the use of a secure digital tool for sharing videos of suspected seizures in children.
Researchers conducted a study to understand how effective first-line antiseizure medications (ASMs) are for children newly diagnosed with epilepsy.
Researchers conducted a study to examine the experiences and outcomes of pregnant individuals with epilepsy.
Researchers investigated the use of intravenous (i/v) levetiracetam (LEV) as a first-line treatment for patients experiencing non-convulsive status epilepticus (NCSE), a serious condition where seizures occur without noticeable convulsions.